Mouwasat Medical Services Company (TADAWUL:4002)
Saudi Arabia · Delayed Price · Currency is SAR 64.65
-0.10 (-0.15%)
Jun 11, 2026, 3:11 PM AST
TADAWUL:4002 Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, TADAWUL:4002 stock has a consensus rating of "Buy" and an average price target of SAR 87.61. The average 1-year stock price forecast is 35.51% higher than the current stock price, while the lowest is SAR 63.00 (-2.55%) and the highest is SAR 118.00 (+82.52%).
Price Target: SAR 87.61 (+35.51%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TADAWUL:4002 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 5 | 5 | 6 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 5 | 5 | 6 | 5 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 1 | 1 | 0 |
| Total | 10 | 10 | 10 | 12 | 12 | 12 |
Financial Forecast
Revenue This Year
3.66B
from 3.22B
Increased by 13.50%
Revenue Next Year
4.13B
from 3.66B
Increased by 12.83%
EPS This Year
4.39
from 4.11
Increased by 6.74%
EPS Next Year
4.80
from 4.39
Increased by 9.48%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.7B | ||
| Avg | 3.7B | ||
| Low | 3.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.8% | ||
| Avg | 13.5% | ||
| Low | 12.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.46 | ||
| Avg | 4.39 | ||
| Low | 4.28 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.5% | ||
| Avg | 6.7% | ||
| Low | 4.1% |